You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 108 No. 2, Aug 1961 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Drug Therapy of Hypertension

V. Observations on the Results with Ganglion-Blocking Agents Given in Combination with Rauwolfia and Chlorothiazide

JOHN H. MOYER, M.D.; ALBERT N. BREST, M.D.

Arch Intern Med. 1961;108(2):231-247.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

During the past 10 years many different drugs with direct and indirect actions upon the sympathetic nervous system have been used for the treatment of diastolic hypertension. Some of these drugs produce a central depressant effect on the hypothalamus with a secondary inhibition of the medullary vasomotor center; others exert their action at peripheral sites by blocking the release of levarterenol or depressing the neuroeffector site within the arteriolar walls. A third group of drugs exert their antihypertensive effect by depressing the autonomic ganglia. It now appears that the use of ganglion-blocking agents in combination with central depressant drugs and diuretics is the most effective method of blood pressure reduction in patients with moderate and severe diastolic blood pressure elevation.

The first available ganglion-blocking agent for the treatment of hypertension was tetraethyl ammonium1-4; subsequently a variety of other ganglioplegic drugs were introduced.5-35 All of these compounds produce their . . . [Full Text PDF of this Article]


Author Affiliations

PHILADELPHIA

Hypertension Unit, Hahnemann Medical College and Hospital.; Professor and Head, Department of Internal Medicine (Dr. Moyer); Director, Hypertension Unit (Dr. Brest).


Footnotes

Submitted for publication June 7, 1960.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1961 American Medical Association. All Rights Reserved.